Enalapril, A Rash, and Captopril
Authors: SPENCER H. KUBO
Journal: Annals of Internal Medicine (1984)

Letters and Corrections1 April 1984Enalapril, A Rash, and CaptoprilSPENCER H. KUBO, M.D., ROBERT J. CODY, M.D.SPENCER H. KUBO, M.D.Search for more papers by this author, ROBERT J. CODY, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-100-4-616_1 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTo the editor: We read with interest the letters by Wilken (1) and Gavras and Gavras (2) concerning adverse reactions due to the converting enzyme inhibitors, captopril and enalapril. Initial experience with enalapril has been favorable in terms of clinical efficacy and tolerability (3), especially for patients who develop side effects to captopril (2, 4). We report an adverse mucocutaneous reaction to enalapril in a patient with congestive heart failure who subsequently tolerated captopril without any adverse reaction.A 55-year-old man had an idiopathic dilated cardiomyopathy and severe congestive heart failure, despite treatment with digoxin, prazosin, captopril, furosemide, isosorbide, procainamide,...References1. WILKIN J. Captopril and enalapril [Letter]. Ann Intern Med. 1983;99:281. LinkGoogle Scholar2. GAVRASGAVRAS IH. Captopril and enalapril [Letter]. Ann Intern Med. 1983;98:556-7. LinkGoogle Scholar3. CODYCOVITSCHAERLARAGH RAGJ. Evaluation of a long-acting converting enzyme inhibitor (enalapril) for the treatment of chronic congestive heart failure. J Am Coll Cardiol. 1983;1:1154-9. CrossrefMedlineGoogle Scholar4. LEVINEOLIVARICOHN TMJ. Acute and long-term response to MK-421, a long acting oral converting enzyme inhibitor, in heart failure [Abstract]. Circulation. 1982;66(suppl 2): II-209. Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: The New York Hospital—Cornell Medical Center New York, NY 10021 PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byThe spectrum of nephrocutaneous diseases and associationsO ral A dverse D rug R eactions to C ardiovascular D rugsAdverse Dermatologic Effects of Cardiovascular Drug Therapy: Part IIDrug-related pemphigus and angiotensin converting enzyme inhibitorsEnalapril-induced toxic pustulodermaAdverse Effects of the Angiotensin-Converting Enzyme InhibitorsEnalapril-induced lichen planus-like eruptionAn Ill Woman with SLE Who Got Worse with TreatmentNitroprusside, Nitroglycerin, and Angiotensin-Converting Enzyme InhibitorsEnalapril induced angioedemaTolerability of Long Term Therapy with Enalapril Maleate in Patients Resistant to Other Therapies and Intolerant to CaptoprilHigh-risk patients treated with enalapril maleate: safety considerationsAngiotensin-converting enzyme inhibitors implicated in oral mucosal lichenoid reactionsConverting-Enzyme Inhibitors in the Treatment of HypertensionSafety issues during antihypertensive treatment with angiotensin converting enzyme inhibitorsSafety issues during antihypertensive treatment with angiotensin converting enzyme inhibitorsAngiotensin-Converting Enzyme InhibitorsAdverse Reactions with Angiotensin Converting Enzyme (ACE) InhibitorsEnalapril: A New Angiotensin Converting Enzyme InhibitorAntihypertensive agentsAngiotensin converting enzyme inhibitionPoints: Treatment of cysticercosisPoints: Treatment with nifedipine for malignant hypertension inducing acute reversible renal impairmentPoints: Focal epilepsy in diabetic nonketotic hyperglycaemiaPoints: Is peritoneal dialysis a good long term treatment?Points: Sleep in the surgical intensive care unitPoints: Acute renal failure in pregnancy secondary to idiopathic hydronephrosisPoints: Section 63 paymentsPoints: Diagnosing the devastatingPoints: Severe cutaneous reactions to captoprilPoints: Needs and opportunities in rehabilitationClinical and hemodynamic experience with enalapril in congestive heart failure 1 April 1984Volume 100, Issue 4Page: 616-616KeywordsAdverse reactionsDilated cardiomyopathyEnzyme inhibitorsHeart failureRashes ePublished: 1 December 2008 Issue Published: 1 April 1984 PDF downloadLoading ...